MUC1 and neoplasm: Because MUC1 antigen is abundantly expressed and aberrantly glycosylated in carcinomas, the tumor associated glycopeptides and epitopes which are masked in normal cells are considered an attractive target in cancer immunotherapy and immunodiagnostics and have been the subject of intensive research efforts [80–82].